ArticleCancer management and research2021

Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer.

Lei Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.